🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the effects on microbiota composition after the administration ...
Status
Completed
Location
Centro Polispecialistico Giovanni Paolo I°
Start Date
2023-01-30
Trial ID
NCT05674318
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as paclitaxel, work in differen...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2006-02
Trial ID
NCT00313599
Treatments Being Tested
This is an open-label, parallel controlled, phase IIa exploratory study tha...
Status
Unknown
Location
Multiple Locations
Start Date
2020-07-15
Trial ID
NCT04446663
Treatments Being Tested
Albumin is a key regulator of fluid distribution within the extracellular s...
Status
Terminated
Location
Klinikum Augsburg, Klinik für Anästhesiologie und Operative Intensivmedizin
Start Date
2019-10-21
Trial ID
NCT03869385
Treatments Being Tested
Aim of this study is to determine in chronic kidney disease patients: * th...
Status
Completed
Location
AIDER
Start Date
2016-01-04
Trial ID
NCT02806089
This study will look at the efficacy and safety of QL1706 plus albumin-boun...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05-06
Trial ID
NCT06404463
This study is looking to see whether the combination of Tucidinostat and na...
Status
Unknown
Location
Hunan Cancer Hospital
Start Date
2023-02-07
Trial ID
NCT05633914
Treatments Being Tested
This study is a single arm, open label, national multicenter study, to expl...
Status
Unknown
Location
Fujian Cancer Hospital
Start Date
2020-08-26
Trial ID
NCT04459078
Treatments Being Tested
The study is a first-in-human (FIH), open-label, multi-center phase 1/2 stu...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-04-29
Trial ID
NCT06385925
Sarcopenia is a risk factor for adverse outcome in critically ill patients....
Status
Unknown
Location
Multiple Locations
Start Date
2022-10
Trial ID
NCT05594550
Treatments Being Tested